Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Dec;91(12):1593-5.
doi: 10.1136/bjo.2006.111872. Epub 2007 Jan 3.

The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema

L L Knudsen  1 , H-H Lervang, S Lundbye-Christensen, A Gorst-Rasmussen
Affiliations

The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema

L L Knudsen et al. Br J Ophthalmol. 2007 Dec.

Abstract

Background: The influence of non-ophthalmic parameters on the prevalence of clinically significant macular oedema has not been unambiguously established. The present study was initiated with the aim of clarification.

Methods: This cross-sectional study comprised 656 type 1 and 328 type 2 diabetic subjects undergoing retinopathy screening in the county of North Jutland. The association between the presence of clinically significant macular oedema and blood pressure, HbA1c, BMI, age, onset of diabetes, duration of diabetes, blood-pressure-reducing medication, lipid-lowering medication, neuropathy and urinary albumin excretion was explored using multiple logistic regression analysis.

Results: We found no significant association between the presence of clinically significant macular oedema and any of the examined parameters in type 1 diabetic subjects. In type 2 diabetic subjects, the duration of diabetes, HbA1c, neuropathy and increased urinary albumin excretion was significantly associated with the presence of clinically significant macular oedema.

Conclusions: The risk factors for clinically significant macular oedema differ in type 1 and type 2 diabetic subjects and can account only in part for this manifestation.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. National Society to Prevent Blindness Vision problems in the U.S. Data analysis, definitions, data sources, detailed data tables, analysis, interpretation. New York: National Society to Prevent Blindness, 1980
    1. Klein R, Klein B E K. Vision disorders in diabetes. In: Diabetes in America. National Diabetes datagroup. 2nd ed. Bethesda: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 1995:293–338 (NIH Publication No. 95‐1468)
    1. Sjølie A K. Ocular complications in insulin‐treated diabetes mellitus. Acta Ophthalmol 1985172(Suppl)1–76S. - PubMed
    1. Klein R, Klein B E K, Moss S E.et al The Wisconsin epidemiologic study of diabetic retinopathy. IV Diabetic macular oedema. Ophthalmology 1984911464–1474. - PubMed
    1. Klein R, Moss S E, Klein B E K.et al The Wisconsin epidemiologic study of diabetic retinopathy. XI The incidence of macular oedema. Ophthalmology 1989961501–1510. - PubMed

MeSH terms

Substances